These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2287594)

  • 1. Pulmonary corpora amylacea contain surfactant apoprotein.
    Akino T; Mizumoto M; Shimizu H; Kuroki Y; Dempo K; Tsuda T; Yanai S; Mizuki M
    Pathol Res Pract; 1990 Oct; 186(5):687-91; discussion 691-5. PubMed ID: 2287594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
    McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
    Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
    Sugiyama K; Kawai T
    Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke.
    Subramaniam S; Whitsett JA; Hull W; Gairola CG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):274-80. PubMed ID: 8887443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
    Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
    Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases.
    Honda Y; Tsunematsu K; Suzuki A; Akino T
    Lung; 1988; 166(5):293-301. PubMed ID: 3146676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and biochemical characterization of pulmonary surfactant protein A of horses.
    Hobo S; Ogasawara Y; Kuroki Y; Akino T; Yoshihara T
    Am J Vet Res; 1999 Feb; 60(2):169-73. PubMed ID: 10048546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of immunohistochemically detected surfactant--apoprotein-A in malignant tumors located in the lungs: report of two cases.
    Goldmann T; Galle J; Wiedorn KH; Deutschbein ME; Neuhaus M; Branscheid D; Vollmer E
    Ann Diagn Pathol; 2001 Apr; 5(2):84-90. PubMed ID: 11294993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alveolar type II cells as a model for investigating the metabolism of surfactant phospholipids.
    Anceschi MM
    Eur Respir J Suppl; 1989 Mar; 3():10s-12s. PubMed ID: 2742680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases.
    Wattiez R; Hermans C; Cruyt C; Bernard A; Falmagne P
    Electrophoresis; 2000 Jul; 21(13):2703-12. PubMed ID: 10949149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant protein A in bronchoalveolar lavage fluid.
    van de Graaf EA; Jansen HM; Lutter R; Alberts C; Kobesen J; de Vries IJ; Out TA
    J Lab Clin Med; 1992 Aug; 120(2):252-63. PubMed ID: 1500824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and ontogenetic relationships of rat lung surfactant apoproteins.
    Katyal SL; Singh G
    Exp Lung Res; 1984; 6(3-4):175-89. PubMed ID: 6548441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.
    Yu SH; Possmayer F
    Biochem J; 1986 May; 236(1):85-9. PubMed ID: 3098235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical and clinical aspects of pulmonary surfactant proteins].
    Akino T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():5-14. PubMed ID: 1306239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in surfactant research with particular reference to its apoproteins].
    Kuroki Y; Akino T
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):524-32. PubMed ID: 2024030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of fetal lung maturity by immunological measurement of fetal pulmonary surfactant apoproteins in amniotic fluid (author's transl)].
    Hirano H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):889-98. PubMed ID: 6809865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid of lung surfactant apoprotein, SP 28-36, is not required for the Ca2+-mediated interactions between surfactant lipids and SP 28-36.
    Efrati H; Hawgood S
    Biochim Biophys Acta; 1987 Feb; 917(3):425-7. PubMed ID: 3801512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of surfactant apoproteins in usual interstitial pneumonia associated with pulmonary carcinoma.
    Chung JH; Kitaichi M; Ham EK; Seo JW
    Microsc Res Tech; 1998 Aug; 42(3):234-8. PubMed ID: 9764924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of amiodarone pneumonitis as related to inflammatory cells and surfactant apoprotein.
    Nagata N; Suematsu R; Yoshii C; Miyazaki H; Sueishi K; Kido M
    Chest; 1997 Oct; 112(4):1068-74. PubMed ID: 9377919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein deficiency in familial interstitial lung disease.
    Amin RS; Wert SE; Baughman RP; Tomashefski JF; Nogee LM; Brody AS; Hull WM; Whitsett JA
    J Pediatr; 2001 Jul; 139(1):85-92. PubMed ID: 11445799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.